In a 4T1breast cancer mouse model, this nanomedicine was shown to outperformclinically used LPS and IFN-γ, and elicit strong antitumor activitiesof TAMs, leading to phagocytic killing and metastasis inhibition. Here, IFNG is linked to cancer.